149 related articles for article (PubMed ID: 17343614)
21. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of homing-associated adhesion molecules by T cell subsets in man.
Picker LJ; Terstappen LW; Rott LS; Streeter PR; Stein H; Butcher EC
J Immunol; 1990 Nov; 145(10):3247-55. PubMed ID: 1700003
[TBL] [Abstract][Full Text] [Related]
23. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells.
Picker LJ; Treer JR; Ferguson-Darnell B; Collins PA; Bergstresser PR; Terstappen LW
J Immunol; 1993 Feb; 150(3):1122-36. PubMed ID: 7678617
[TBL] [Abstract][Full Text] [Related]
24. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites.
Picker LJ; Martin RJ; Trumble A; Newman LS; Collins PA; Bergstresser PR; Leung DY
Eur J Immunol; 1994 Jun; 24(6):1269-77. PubMed ID: 7515808
[TBL] [Abstract][Full Text] [Related]
26. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
27. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
Iellem A; Colantonio L; D'Ambrosio D
Eur J Immunol; 2003 Jun; 33(6):1488-96. PubMed ID: 12778466
[TBL] [Abstract][Full Text] [Related]
28. Immunopathology of leprosy skin lesions.
Rea TH; Modlin RL
Semin Dermatol; 1991 Sep; 10(3):188-93. PubMed ID: 1931567
[TBL] [Abstract][Full Text] [Related]
29. Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes.
Koelle DM; Huang J; Hensel MT; McClurkan CL
J Virol; 2006 Mar; 80(6):2863-72. PubMed ID: 16501095
[TBL] [Abstract][Full Text] [Related]
30. Expression of alpha4beta7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites.
Rott LS; Briskin MJ; Butcher EC
J Leukoc Biol; 2000 Dec; 68(6):807-14. PubMed ID: 11129647
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous lymphocyte-associated antigen expression in children with atopic dermatitis and non-atopic healthy children.
Campbell DE; Kemp AS
Pediatr Allergy Immunol; 1999 Nov; 10(4):253-7. PubMed ID: 10678721
[TBL] [Abstract][Full Text] [Related]
32. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
33. Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients.
Ohman R; Walford C; Converse P; Ridell M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):320-2. PubMed ID: 2071990
[No Abstract] [Full Text] [Related]
34. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
[TBL] [Abstract][Full Text] [Related]
35. Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression.
Yamanaka K; Dimitroff CJ; Fuhlbrigge RC; Kakeda M; Kurokawa I; Mizutani H; Kupper TS
J Allergy Clin Immunol; 2008 Jan; 121(1):148-157.e3. PubMed ID: 17910894
[TBL] [Abstract][Full Text] [Related]
36. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
[TBL] [Abstract][Full Text] [Related]
37. Inside the skin: the local immune and inflammatory milieu in leprosy.
Scollard DM
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
[TBL] [Abstract][Full Text] [Related]
38. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
[TBL] [Abstract][Full Text] [Related]
39. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
Rada EM; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
[No Abstract] [Full Text] [Related]
40. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
